期刊论文详细信息
JOURNAL OF CONTROLLED RELEASE 卷:163
Improvement of drug safety by the use of lipid-based nanocarriers
Article; Proceedings Paper
Onyuksel, Hayat1,2 
[1] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA
关键词: Lipid nanocarriers;    Drug safety;    Micelles;    Liposomes;    Solid lipid nanoparticle;   
DOI  :  10.1016/j.jconrel.2012.06.002
来源: Elsevier
PDF
【 摘 要 】

Drug toxicity is an important factor that contributes significantly to adverse drug events in current healthcare practice. Application of lipid-based nanocarriers in drug formulation is one approach to improve drug safety. Lipid-based delivery systems include micelles, liposomes, solid lipid nanoparticles, nanoemulsions and nanosuspensions. These carriers are generally composed of physiological lipids well tolerated by human body. Delivery of water-insoluble drugs in these formulations increases their solubility and stability in aqueous media and eliminates the need for toxic co-solvents or pH adjustment to solubilize hydrophobic drugs. Association or encapsulation of peptides/proteins within lipid-based carriers protects the labile biologics against enzymatic degradation, hence reducing the therapeutic dose required and risk of dose-dependent toxicity. Most importantly, lipid-based nanocarriers alter the pharmacokinetics and biodistribution of drugs through passive and active targeting, leading to increased drug accumulation at target sites while significantly decreasing non-specific distribution to other tissues. Furthermore, surface modification of these nanocarriers reduces immunogenicity of drug-carrier complexes, imparts stealth by preventing opsonization and removal by phagocytes and minimizes interaction with circulating blood components. In view of heightening attention on drug safety in patient treatment, lipid-based nanocarrier is therefore an important and promising option for formulation of pharmaceutical products to improve treatment safety and efficacy. (C) 2012 Elsevier B.V. All rights reserved.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jconrel_2012_06_002.pdf 660KB PDF download
  文献评价指标  
  下载次数:27次 浏览次数:2次